CDNA vs LEN · rev $333.8M vs rev $34.19B
CareDx Inc (CDNA) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
CareDx Inc (CDNA) is a diagnostics & research company listed on US.
LEN (LEN) common stock.
Latest reported CDNA revenue for 2024-12-31 was $333.8M. Net income was $52.5M. Revenue was up 19.1% from 2023-12-31 to 2024-12-31. CDNA currently screens at market cap $1.18B.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
CDNA currently screens at market cap $1.18B. LEN currently screens at market cap $0.
Not investment advice. Open the CDNA and LEN stock pages for the full models.
Not investment advice.